Genentech
Genentech, the U.S. arm of drug giant Roche, offered
the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Two of its well-known anti-cancer drugs are Herceptin and Avastin.
Latest
STAT Plus: EPA fines Roche’s Genentech unit for hazardous waste violations
STAT Plus: Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform
Doctors use precision medicine to show melanoma drugs can shrink rare brain tumor by 90%
STAT Plus: Roche shortens delivery time for multiple sclerosis drug from hours to minutes in trial
STAT Plus: Genentech review of Tessier-Lavigne paper finds no evidence of fraud — but hints at a different misconduct case
Same patient, same drug, same insurer — coverage denied
